(Q45607904)
Statements
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design (English)
G R Pond
J Bellmunt
D F Bajorin
T K Choueiri
A Q Qu
P Albers
G Di Lorenzo
R Fougeray
Y-N Wong
S S Sridhar
Y-J Ko
M I Milowsky
M D Galsky